Shares of other companies:
April 27, 2024 Alphabet and Microsoft’s AI Investments Yield Strong Returns
April 26, 2024 Top 10 High Dividend Yield Stocks
Tesla Q1: Model 2 Could Be Their Model T
April 25, 2024
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
April 12, 2024 Improve Your Financial Status: A How-To Guide
Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
AFMD Stock News and Mentions of Affimed N.V. Stocktwits
Updated: April 28, 2024 (09:14)
Sector: Healthcare
Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.
We meticulously analyze the sentiment trend in each article for the last 60 days where Affimed N.V. Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of Affimed N.V. (AFMD).
You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the Affimed N.V. stocks.
Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles
News and Mentions of Affimed N.V. (AFMD)
April 24, 2024 (13:55) / "Zacks Commentary" (by Zacks Equity Research)
Wall Street Analysts Believe Affimed N.V. ( AFMD ) Could Rally 146.73%: Here's is How to Trade
The consensus price target hints at a 146.7% upside potential for Affimed N.V. (AFMD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
In Article Trend: Somewhat-Bullish
April 24, 2024 (08:05) / "GlobeNewswire" (by Affimed N.V.)
Affimed Announces Acceptance of AFM24 Clinical Abstract at the 2024 Annual Meeting of the American Society of Clinical Oncology
MANNHEIM, Germany, April 24, 2024 ( GLOBE NEWSWIRE ) -- Affimed N.V. ( Nasdaq: AFMD ) , a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced that an abstract presenting preliminary data from the phase 2 combination study ...
In Article Trend: Neutral
April 17, 2024 (13:55) / "Zacks Commentary" (by Zacks Equity Research)
Affimed N.V. ( AFMD ) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
After losing some value lately, a hammer chart pattern has been formed for Affimed N.V. (AFMD), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
In Article Trend: Somewhat-Bullish
April 4, 2024 (13:55) / "Zacks Commentary" (by Zacks Equity Research)
Does Affimed N.V. ( AFMD ) Have the Potential to Rally 263.36% as Wall Street Analysts Expect?
The consensus price target hints at a 263.4% upside potential for Affimed N.V. (AFMD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
In Article Trend: Somewhat-Bullish
March 28, 2024 (10:30) / "GlobeNewswire" (by Affimed N.V.)
Affimed Reports 2023 Financial Results and Operational Progress
MANNHEIM, Germany, March 28, 2024 ( GLOBE NEWSWIRE ) -- Affimed N.V. ( Nasdaq: AFMD ) ( "Affimed" or the "Company" ) , a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today reported financial results and provided an update on ...
In Article Trend: Neutral
March 21, 2024 (10:30) / "GlobeNewswire" (by Affimed N.V.)
Affimed To Report Full Year 2023 Financial Results & Corporate Update on March 28, 2024
MANNHEIM, Germany, March 21, 2024 ( GLOBE NEWSWIRE ) -- Affimed N.V. ( Nasdaq: AFMD ) ( "Affimed" or the "Company" ) , a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that it will release full year 2023 results and ...
In Article Trend: Neutral
March 14, 2024 (16:00) / "Zacks Commentary" (by Zacks Equity Research)
Affimed N.V. ( AFMD ) Upgraded to Buy: Here's What You Should Know
Affimed N.V. (AFMD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
In Article Trend: Somewhat-Bullish
March 6, 2024 (11:30) / "GlobeNewswire" (by Affimed N.V.)
Affimed Announces 1-for-10 Reverse Stock Split
MANNHEIM, Germany, March 06, 2024 ( GLOBE NEWSWIRE ) -- Affimed N.V. ( Nasdaq: AFMD ) ( "Affimed" or the "Company" ) , a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced that the Company, with prior approval of the Company's ...
In Article Trend: Neutral
February 29, 2024 (23:00) / "Zacks Commentary" (by Zacks Equity Research)
Seer, Inc. ( SEER ) Reports Q4 Loss, Tops Revenue Estimates
Seer, Inc. (SEER) delivered earnings and revenue surprises of 20% and 4.79%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
In Article Trend: Neutral
Related stocks from Healthcare sector
This website uses cookies to ensure you get the best experience on our website